IBDEI2GX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39415,1,3,0)
 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
 ;;^UTILITY(U,$J,358.3,39415,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,39415,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,39416,0)
 ;;=F52.21^^152^1997^33
 ;;^UTILITY(U,$J,358.3,39416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39416,1,3,0)
 ;;=3^Erectile Disorder,Male (Psychogenic)
 ;;^UTILITY(U,$J,358.3,39416,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,39416,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,39417,0)
 ;;=I12.9^^152^1997^59
 ;;^UTILITY(U,$J,358.3,39417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39417,1,3,0)
 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
 ;;^UTILITY(U,$J,358.3,39417,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,39417,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,39418,0)
 ;;=N04.9^^152^1997^76
 ;;^UTILITY(U,$J,358.3,39418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39418,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,39418,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,39418,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,39419,0)
 ;;=N02.9^^152^1997^53
 ;;^UTILITY(U,$J,358.3,39419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39419,1,3,0)
 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
 ;;^UTILITY(U,$J,358.3,39419,1,4,0)
 ;;=4^N02.9
 ;;^UTILITY(U,$J,358.3,39419,2)
 ;;=^5015520
 ;;^UTILITY(U,$J,358.3,39420,0)
 ;;=N06.9^^152^1997^93
 ;;^UTILITY(U,$J,358.3,39420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39420,1,3,0)
 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
 ;;^UTILITY(U,$J,358.3,39420,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,39420,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,39421,0)
 ;;=N05.9^^152^1997^73
 ;;^UTILITY(U,$J,358.3,39421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39421,1,3,0)
 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,39421,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,39421,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,39422,0)
 ;;=N07.9^^152^1997^75
 ;;^UTILITY(U,$J,358.3,39422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39422,1,3,0)
 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
 ;;^UTILITY(U,$J,358.3,39422,1,4,0)
 ;;=4^N07.9
 ;;^UTILITY(U,$J,358.3,39422,2)
 ;;=^5015568
 ;;^UTILITY(U,$J,358.3,39423,0)
 ;;=N15.9^^152^1997^100
 ;;^UTILITY(U,$J,358.3,39423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39423,1,3,0)
 ;;=3^Renal Tubulo-Interstitial Disease,Unspec
 ;;^UTILITY(U,$J,358.3,39423,1,4,0)
 ;;=4^N15.9
 ;;^UTILITY(U,$J,358.3,39423,2)
 ;;=^5015596
 ;;^UTILITY(U,$J,358.3,39424,0)
 ;;=N17.9^^152^1997^65
 ;;^UTILITY(U,$J,358.3,39424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39424,1,3,0)
 ;;=3^Kidney Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,39424,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,39424,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,39425,0)
 ;;=N19.^^152^1997^66
 ;;^UTILITY(U,$J,358.3,39425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39425,1,3,0)
 ;;=3^Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,39425,1,4,0)
 ;;=4^N19.
 ;;^UTILITY(U,$J,358.3,39425,2)
 ;;=^5015607
 ;;^UTILITY(U,$J,358.3,39426,0)
 ;;=N11.0^^152^1997^97
 ;;^UTILITY(U,$J,358.3,39426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39426,1,3,0)
 ;;=3^Pyelonephritis,Chronic Nonobstructive Reflux-Associated
 ;;^UTILITY(U,$J,358.3,39426,1,4,0)
 ;;=4^N11.0
 ;;^UTILITY(U,$J,358.3,39426,2)
 ;;=^5015571
 ;;^UTILITY(U,$J,358.3,39427,0)
 ;;=N10.^^152^1997^74
